A detailed history of Bbr Partners, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Bbr Partners, LLC holds 16,444 shares of FGEN stock, worth $7,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,444
Previous 16,444 -0.0%
Holding current value
$7,893
Previous $14,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$0.89 - $2.36 $178,000 - $472,000
-200,000 Reduced 92.4%
16,444 $14,000
Q1 2024

May 13, 2024

BUY
$0.73 - $2.73 $146,000 - $546,000
200,000 Added 1216.25%
216,444 $508,000
Q4 2023

Feb 12, 2024

BUY
$0.38 - $0.91 $6,248 - $14,964
16,444 New
16,444 $14,000
Q2 2021

Aug 13, 2021

SELL
$18.57 - $35.68 $131,029 - $251,758
-7,056 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$37.97 - $60.16 $18,985 - $30,080
500 Added 7.63%
7,056 $327,000
Q4 2017

Feb 08, 2018

BUY
$41.95 - $60.1 $41,950 - $60,100
1,000 Added 18.0%
6,556 $311,000
Q3 2017

Nov 14, 2017

BUY
$33.4 - $53.9 $185,570 - $299,468
5,556
5,556 $299,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $45M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.